Danyi Wang

Structural Optimization of Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors.

Xutong Li, M. Geng, Hong Liu, 2023, Journal of medicinal chemistry.

Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers.

Yupeng Li, Guizhen Zhou, Tianfeng Xu, 2023, Journal of medicinal chemistry.

Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors

Yu Zhou, Chunpu Li, Yin-chun Ji, 2023, Acta pharmaceutica Sinica. B.